Introduction Leptospiros is thought to be the most widespread zoonosis in the world. A systematic review estimated that there are
INCACARE
Welcome To
Incacare Live
Incacare Live is an initiative by Concord Biotech to keep you updated with recent advances in critical care. The website shares information regarding incidences of opportunistic fungal infections in patients.
Concord Biotech is a vertically integrated, R&D driven biotechnological powerhouse manufacturing API’s and Finished formulations, offers products across diversified therapeutic segments.
Blog
INTENSIVE CARE UPDATES
Transforming sepsis management: AI-driven innovations in early detection and tailored therapies
Introduction Sepsis remains a major global health challenge due to its complexity and delayed recognition. Artificial intelligence (AI) shows promise
Epidemiology and risk factors of fungal pathogens in sepsis: a prospective nationwide multicenter cohort study
Introduction Sepsis is a life-threatening condition, and fungal pathogens are an increasingly important cause, especially in high-risk groups. During COVID-19,
Immunothrombosis in Sepsis: Cellular Crosstalk, Molecular Triggers and Therapeutic Opportunities
Introduction Sepsis is a critical medical emergency caused by an uncontrolled immune response to infection, resulting in organ dysfunction. It
Introduction Antimicrobial resistance (AMR) is a major global health threat. According to the CDC (2019), over 2.8 million antibiotic-resistant infections
Introduction Antibiotic-resistant bacteria are a growing global threat, causing longer hospital stays, higher costs, and increased mortality. The rise of







